{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:31:54Z","timestamp":1791145914998,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2000,11,1]],"date-time":"2000-11-01T00:00:00Z","timestamp":973036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,11,1]],"date-time":"2000-11-01T00:00:00Z","timestamp":973036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2000,11,1]]},"DOI":"10.1038\/sj.leu.2401928","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T18:27:43Z","timestamp":1031164063000},"page":"1997-2005","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Quantitation of DNA topoisomerase II\u03b1 and \u03b2 in human leukaemia cells by immunoblotting"],"prefix":"10.1038","volume":"14","author":[{"given":"K","family":"Padget","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ADJ","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CA","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2000,11,2]]},"reference":[{"key":"BF2401928_CR1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1146\/annurev.bi.65.070196.003223","volume":"65","author":"JC Wang","year":"1996","unstructured":"Wang JC . DNA topoisomerases Ann Rev Biochem 1996 65: 635\u2013692","journal-title":"Ann Rev Biochem"},{"key":"BF2401928_CR2","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1073\/pnas.81.9.2616","volume":"81","author":"S DiNardo","year":"1984","unstructured":"DiNardo S, Voelkel K, Sternglanz R . DNA topoisomerase II mutant of Saccharomyces cerevisiae topoisomerase II is required for segregation of daughter molecules at the termination of DNA replication Proc Natl Acad Sci USA 1984 81: 2616\u20132620","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2401928_CR3","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1128\/MCB.8.2.515","volume":"8","author":"RM Snapka","year":"1988","unstructured":"Snapka RM, Powelson MA, Strayer JM . Swiveling and decatenation of replicating simian virus 40 genomes in vivo Mol Cell Biol 1988 8: 515\u2013523","journal-title":"Mol Cell Biol"},{"key":"BF2401928_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0092-8674(91)90215-K","volume":"64","author":"Y Adachi","year":"1991","unstructured":"Adachi Y, Luke M, Laemmli UK . Chromosome assembly in vitro: topoisomerase II is required for condensation Cell 1991 64: 137\u2013148","journal-title":"Cell"},{"key":"BF2401928_CR5","doi-asserted-by":"publisher","first-page":"8154","DOI":"10.1021\/bi00446a029","volume":"28","author":"FH Drake","year":"1989","unstructured":"Drake FH, Hoffmann GA, Bartus HF, Mattern MR, Crooke ST, Mirabelli CK . Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II Biochemistry 1989 28: 8154\u20138160","journal-title":"Biochemistry"},{"key":"BF2401928_CR6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1124\/mol.54.1.78","volume":"53","author":"E Willmore","year":"1998","unstructured":"Willmore E, Frank AJ, Padget K, Tilby MJ, Austin CA . Etoposide targets topoisomerase II\u03b1 and II\u03b2 in leukaemia cells: isoform-specific cleavable complexes visualised and quantified in situ by a novel immunofluorescence technique Mol Pharmacol 1998 53: 78\u201385","journal-title":"Mol Pharmacol"},{"key":"BF2401928_CR7","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1007\/BF00684858","volume":"34","author":"WT Beck","year":"1994","unstructured":"Beck WT, Kim R, Chen M . Novel actions of inhibitors of DNA topoisomerase II in drug-resistant tumour cells Cancer Chemother Pharmacol 1994 34: S14\u2013S18","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF2401928_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1146\/annurev.pa.34.040194.001203","volume":"34","author":"AY Chen","year":"1994","unstructured":"Chen AY, Liu LF . DNA topoisomerases: essential enzymes and lethal targets Ann Rev Pharmacol Toxicol 1994 34: 191\u2013218","journal-title":"Ann Rev Pharmacol Toxicol"},{"key":"BF2401928_CR9","first-page":"6543","volume":"51","author":"CD Webb","year":"1991","unstructured":"Webb CD, Latham MD, Lock RB, Sullivan DM . Attenuated topoisomerase II content directly correlates with a low level of drug resistance in a Chinese hamster ovary cell line Cancer Res 1991 51: 6543\u20136549","journal-title":"Cancer Res"},{"key":"BF2401928_CR10","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1073\/pnas.89.8.3498","volume":"89","author":"EWHM Eijdems","year":"1992","unstructured":"Eijdems EWHM, Borst P, Jongsma APM, DeJong S, De Viries EGE, Van Groenigen M, Versantvoort CHM, Nienwint AWM, Baas F . Genetic transfer of non-P-glycoprotein-mediated multi-drug resistance (MDR) in somatic cell fusion: dissection of a compound MDR phenotype Proc Natl Acad Sci USA 1992 89: 3498\u20133502","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2401928_CR11","first-page":"78","volume":"55","author":"GA Brown","year":"1995","unstructured":"Brown GA, McPherson JP, Hedley DW, Toso R, Deuchars L, Freedman MH, Goldenburg GJ . Relationship of DNA topoisomerase II\u03b1 and \u03b2 expression to cytotoxicity of antineoplastic agents in human acute lymphoblastic leukaemia cell lines Cancer Res 1995 55: 78\u201382","journal-title":"Cancer Res"},{"key":"BF2401928_CR12","first-page":"4301","volume":"57","author":"S Dereuddre","year":"1997","unstructured":"Dereuddre S, Delaporte C, Jacquemin Sablon A . Role of topoisomerase II\u03b2 in the resistance of 9-OH-elliptincine-resistant Chinese hamster fibroblasts to topoisomerase II inhibitors Cancer Res 1997 57: 4301\u20134308","journal-title":"Cancer Res"},{"key":"BF2401928_CR13","first-page":"3591","volume":"53","author":"RA Wasserman","year":"1993","unstructured":"Wasserman RA, Austin CA, Fisher LM, Wang JC . Use of yeast in the study of anticancer drugs targeting DNA topoisomerases: expression of a functional recombinant human DNA topoisomerase II alpha in yeast Cancer Res 1993 53: 3591\u20133596","journal-title":"Cancer Res"},{"key":"BF2401928_CR14","doi-asserted-by":"publisher","first-page":"15739","DOI":"10.1074\/jbc.270.26.15739","volume":"270","author":"CA Austin","year":"1995","unstructured":"Austin CA, Marsh KL, Wasserman RA, Willmore E, Sayer PJ, Wang JC, Fisher ML . Expression, domain structure and enzymatic properties of an active recombinant human DNA topoisomerase II\u03b2 J Biol Chem 1995 270: 15739\u201315746","journal-title":"J Biol Chem"},{"key":"BF2401928_CR15","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.1002\/j.1460-2075.1987.tb02753.x","volume":"6","author":"P Raychandauri","year":"1987","unstructured":"Raychandauri P, Rooney R, Nevins JR . Identification of an E1A-inducible cellular factor that interacts with regulatory sequences within the adenovirus E4 promoter EMBO J 1987 6: 4073\u20134081","journal-title":"EMBO J"},{"key":"BF2401928_CR16","first-page":"4866","volume":"53","author":"SEL Mirski","year":"1993","unstructured":"Mirski SEL, Evans CD, Almquist KC, Slovak ML, Cole SPC . Altered topoisomerase II\u03b1 in a drug-resistant small cell lung cancer cell line selected in VP-16 Cancer Res 1993 53: 4866\u20134873","journal-title":"Cancer Res"},{"key":"BF2401928_CR17","doi-asserted-by":"publisher","first-page":"8861","DOI":"10.1021\/bi00424a026","volume":"27","author":"MK Danks","year":"1988","unstructured":"Danks MK, Schmidt CA, Cirtain MC, Suttle DP, Beck WT . Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukaemic cells selected for resistance to VM-26 Biochemistry 1988 27: 8861\u20138869","journal-title":"Biochemistry"},{"key":"BF2401928_CR18","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1006\/excr.1998.4150","volume":"243","author":"IG Cowell","year":"1998","unstructured":"Cowell IG, Willmore E, Charlton D, Marsh KL, Jazrawi E, Fisher LM, Austin CA . Nuclear distribution of human DNA topoisomerase II\u03b2: a nuclear targeting signal resides in the 116-residue C-terminal tail Exp Cell Res 1998 243: 232\u2013240","journal-title":"Exp Cell Res"},{"key":"BF2401928_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0167-4781(98)00131-6","volume":"1400","author":"RJ Issacs","year":"1998","unstructured":"Issacs RJ, Davies SL, Sandri MI, Redwood C, Wells NJ, Hickson ID . Physiological regulation of eukaryotic topoisomerase II Biochim Biophys Acta 1998 1400: 121\u2013137","journal-title":"Biochim Biophys Acta"},{"key":"BF2401928_CR20","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/j.1460-2075.1985.tb03903.x","volume":"4","author":"MK Darby","year":"1985","unstructured":"Darby MK, Schmitt B, Jongstra Bilen J, Vosberg HP . Inhibition of calf thymus type II DNA topoisomerase by poly (ADP)-ribosylation EMBO J 1985 4: 2129\u20132134","journal-title":"EMBO J"},{"key":"BF2401928_CR21","unstructured":"Medical Research Council UKALL XI (92) Trial for Childhood Acute Lymphoblastic Leukaemia"},{"key":"BF2401928_CR22","first-page":"209","volume":"2","author":"RD Woessner","year":"1991","unstructured":"Woessner RD, Mattern MR, Mirabelli CK, Johnson RK, Drake FH . Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells Cell Growth Diff 1991 2: 209\u2013214","journal-title":"Cell Growth Diff"},{"key":"BF2401928_CR23","first-page":"3534","volume":"51","author":"SH Kaufmann","year":"1991","unstructured":"Kaufmann SH, McLaughlin SJ, Kastan MB, Liu LF, Karp JE, Burke PJ . Topoisomerase II levels during granulocytic maturation in vitro and in vivo Cancer Res 1991 51: 3534\u20133543","journal-title":"Cancer Res"},{"key":"BF2401928_CR24","first-page":"2093","volume":"12","author":"E Prosperi","year":"1992","unstructured":"Prosperi E, Sala E, Negri C, Olianti C, Supino R, Astraldi Ricotti GBC, Bottirola G . Topoisomerase II\u03b1 and \u03b2 in human tumour cells grown in vitro and in vivo Anticancer Res 1992 12: 2093\u20132100","journal-title":"Anticancer Res"},{"key":"BF2401928_CR25","first-page":"2901","volume":"50","author":"RD Woessner","year":"1990","unstructured":"Woessner RD, Chung TD, Hofmann GA, Mattern MR, Mirabelli CK, Drake FH, Johnson RK . Differences between normal and ras-transformed NIH-3T3 cells in expression of the 170 kD and 180 kD forms of topoisomerase II Cancer Res 1990 50: 2901\u20132908","journal-title":"Cancer Res"},{"key":"BF2401928_CR26","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s002800050585","volume":"39","author":"EL Meczes","year":"1997","unstructured":"Meczes EL, Marsh KL, Fisher LM, Rogers MP, Austin CA . Complementation of temperature-sensitive topoisomerase II mutations in Saccharomyces cerevisiae by a human TOP2beta construct allows the study of topoisomerase II\u03b2 inhibitors in yeast Cancer Chemother Pharmacol 1997 39: 367\u2013375","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF2401928_CR27","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1124\/mol.56.6.1309","volume":"56","author":"F Errington","year":"1999","unstructured":"Errington F, Willmore E, Tilby MJ, Li L, Li G, Baguley BC, Austin CA . Murine transgenic cells lacking DNA topoisomerase II\u03b2 are resistant to acridines and mitoxantrone: analysis of cytotoxicity and cleavable complex formation Mol Pharmacol 1999 56: 1309\u20131316","journal-title":"Mol Pharmacol"},{"key":"BF2401928_CR28","doi-asserted-by":"publisher","first-page":"8407","DOI":"10.1073\/pnas.90.18.8407","volume":"90","author":"S Taagepera","year":"1993","unstructured":"Taagepera S, Rao PN, Drake FH, Gorbsky GJ . DNA topoisomerase II\u03b1 is the major chromosome protein recognised by the mitotic phosphoprotein antibody MPM-2 Proc Natl Acad Sci USA 1993 90: 8407\u20138411","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2401928_CR29","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1365-2184.1994.tb01423.x","volume":"27","author":"E Prosperi","year":"1994","unstructured":"Prosperi E, Negri C, Marchese G, Astaldi Ricotti GCB . Expression of the 170-kDa and 180-kDa isoforms of DNA topoisomerase II in resting and proliferating lymphocytes Cell Prolif 1994 27: 257\u2013267","journal-title":"Cell Prolif"},{"key":"BF2401928_CR30","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0021-9258(17)42238-1","volume":"269","author":"K Kimura","year":"1994","unstructured":"Kimura K, Saijo M, Ui M, Enomoto T . Growth state- and cell cycle-dependent fluctuation in the expression of two forms of DNA topoisomerase II and possible specific modification of the higher molecular weight form in the M phase J Biol Chem 1994 269: 1173\u20131176","journal-title":"J Biol Chem"},{"key":"BF2401928_CR31","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/bjc.1997.227","volume":"75","author":"KM Turley","year":"1997","unstructured":"Turley KM, Comley M, Houlbrook S, Nozaki N, Kikuchi A, Hickson ID, Gatter K, Harris AL . The distribution and expression of the two isoforms of DNA topoisomerase II in normal and neoplastic human tissues Br J Cancer 1997 75: 1340\u20131346","journal-title":"Br J Cancer"},{"key":"BF2401928_CR32","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1083\/jcb.103.6.2569","volume":"103","author":"MM Heck","year":"1986","unstructured":"Heck MM, Earnshaw WC . Topoisomerase II: a specific marker for cell proliferation J Cell Biol 1986 103: 2569\u20132581","journal-title":"J Cell Biol"},{"key":"BF2401928_CR33","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1365-2141.1992.tb08899.x","volume":"80","author":"A Hirt","year":"1992","unstructured":"Hirt A, Werren EM, Luethy AR, Gerdes J, Wagner HP . Cell cycle analysis in lymphoid neoplasia of childhood: differences among immunologic subtypes and similarities in the proliferation of normal and leukaemic precursor B cells Br J Haematol 1992 80: 189\u2013193","journal-title":"Br J Haematol"},{"key":"BF2401928_CR34","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1182\/blood.V83.2.517.517","volume":"83","author":"SH Kaufmann","year":"1994","unstructured":"Kaufmann SH, Karp JE, Jones RJ, Miller CB, Schneider E, Zwelling LA, Cowan K, Wendel K, Burke PJ . Topoisomerase II levels and drug sensitivity in adult acute myelogenous leukaemia Blood 1994 83: 517\u2013530","journal-title":"Blood"},{"key":"BF2401928_CR35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3109\/10428199609054804","volume":"23","author":"SH Kaufmann","year":"1996","unstructured":"Kaufmann SH, Karp JE, Burke PJ, Gore SD . Addition of etoposide to initial therapy of adult acute lymphoblastic leukaemia: a combined clinical and laboratory study Leuk Lymphoma 1996 23: 71\u201383","journal-title":"Leuk Lymphoma"},{"key":"BF2401928_CR36","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/j.1365-2141.1999.01353.x","volume":"105","author":"R Zhou","year":"1999","unstructured":"Zhou R, Vitols S, Gruber A, Liliemark J, Wang Y, Liliemark E . Etoposide-induced DNA strand breaks in relation to P-glycoprotein and topoisomerase II protein expression in leukaemic cells from patients with AML and CLL Br J Haematol 1999 105: 420\u2013427","journal-title":"Br J Haematol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2401928.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2401928","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2401928.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T21:41:02Z","timestamp":1648762862000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2401928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11,1]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2000,11,1]]}},"alternative-id":["BF2401928"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2401928","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,11,1]]},"assertion":[{"value":"22 December 1999","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2000","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2000","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}